DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Andersson M, Madsen EL, Overgaard M et al.
Doxorubicin versus methotrexate both combined with cyclophosphamide,
5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast
cancer – a randomised study with more than 10 years follow-up from the Danish
Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group
(DBCG).
Eur J Cancer 1999;
35: 39-46
We do not assume any responsibility for the contents of the web pages of other providers.